0000891293-16-000110.txt : 20160226
0000891293-16-000110.hdr.sgml : 20160226
20160226181809
ACCESSION NUMBER: 0000891293-16-000110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160226
FILED AS OF DATE: 20160226
DATE AS OF CHANGE: 20160226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIANCO JAMES A
CENTRAL INDEX KEY: 0001198554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 161464007
FORMER NAME:
FORMER CONFORMED NAME: BLANCO JAMES A
DATE OF NAME CHANGE: 20021015
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-02-26
0
0000891293
CTI BIOPHARMA CORP
ctic
0001198554
BIANCO JAMES A
3101 WESTERN AVENUE
SUITE 600
SEATTLE
WA
98121
1
1
0
0
President and CEO
Common Stock
2016-02-26
4
S
0
10000
0.6294
D
2138302
D
The sale was effected pursuant to a Rule 10b5-1 trading plan.
By: Louis A. Bianco, Attorney-in-fact For: James A. Bianco
2016-02-26